All bills
H.R. 1703·119th Congress·House Bill

Choices for Increased Mobility Act of 2026

Stage not supplied

The source supplies the latest action, but no lifecycle stage.

Latest action (10 Nov 2026): Signed by President.

What this bill does

H.R. 1703, the Choices for Increased Mobility Act of 2026, would amend Medicare law to change how certain manual wheelchairs are paid for under Part B. Specifically, for ultralightweight manual wheelchairs furnished on or after January 1, 2028, the bill directs the Secretary of Health and Human Services to create separate billing codes based on the construction material used in the wheelchair's base—distinguishing models made with titanium or carbon fiber from those made with other materials.

The bill affects Medicare beneficiaries who need ultralightweight manual wheelchairs, as well as the suppliers who provide them. Under the new rules, if a beneficiary chooses a titanium or carbon-fiber wheelchair, Medicare would pay the supplier the same amount it would otherwise pay for such equipment. However, the supplier could then charge the beneficiary the difference between the supplier's actual price and Medicare's payment. To help beneficiaries understand this potential out-of-pocket cost, the Secretary may require suppliers to notify individuals of their financial liability before the purchase or rental occurs.

The bill passed the House of Representatives on July 20, 2026, by voice vote under a motion to suspend the rules, with an amendment. It now goes to the Senate for consideration. It would need to pass the Senate and be signed by the President before becoming law.

Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.

Official summary

Choices for Increased Mobility Act of 2025

This bill requires the Centers for Medicare & Medicaid Services (CMS) to establish specific billing codes under Medicare for certain materials used in ultralightweight manual wheelchairs.

Specifically, the CMS must establish at least two billing codes for the base of the wheelchair, with at least one code for a base with titanium or carbon fiber construction material and at least one code for a base without these materials. Suppliers receive the same payment under Medicare for these wheelchairs as would otherwise apply, but may bill beneficiaries for any difference between the payment and the actual charge for the wheelchair. The CMS may require suppliers to inform beneficiaries of their potential financial liability in these cases.

Timeline

  1. 10 Nov 2026

    Signed by President.

Common questions

What does H.R. 1703 do?
H.R. 1703, the Choices for Increased Mobility Act of 2026, would amend Medicare law to change how certain manual wheelchairs are paid for under Part B. Specifically, for ultralightweight manual wheelchairs furnished on or after January 1, 2028, the bill directs the Secretary of Health and Human Services to create separate billing codes based on the construction material used in the wheelchair's base—distinguishing models made with titanium or carbon fiber from those made with other materials. The bill affects Medicare beneficiaries who need ultralightweight manual wheelchairs, as well as the suppliers who provide them. Under the new rules, if a beneficiary chooses a titanium or carbon-fiber wheelchair, Medicare would pay the supplier the same amount it would otherwise pay for such equipment. However, the supplier could then charge the beneficiary the difference between the supplier's actual price and Medicare's payment. To help beneficiaries understand this potential out-of-pocket cost, the Secretary may require suppliers to notify individuals of their financial liability before the purchase or rental occurs. The bill passed the House of Representatives on July 20, 2026, by voice vote under a motion to suspend the rules, with an amendment. It now goes to the Senate for consideration. It would need to pass the Senate and be signed by the President before becoming law.
Has H.R. 1703 become law?
The source does not supply a confirmed lifecycle stage for H.R. 1703. Check the latest action and official source below.
Who sponsored H.R. 1703?
H.R. 1703 was sponsored by Rep. Joyce, John [R-PA-13] (R-PA), with 10 cosponsors.
What's the latest action on H.R. 1703?
Signed by President. (10 Nov 2026).

Related bills in Health

More bills from Rep. Joyce, John [R-PA-13]

Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.